Lipid management in ASCVD Learning Zone
The ORION-10 and ORION-11 trials
The infographic below is a summary and comparison of two clinical trials, ORION-10 and ORION-11, which assessed the efficacy and safety of a lipid-lowering drug. Differences in the dosing regimen, changes in LDL-C levels and adverse events are presented in a visual format.
This content has been developed independently by Medthority who previously received educational funding from Novartis Pharma AG in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.